Distinguished Leaders in Biologics Development to Give Keynotes at BioProcess International (BPI) 2014
Keynotes from Abbvie, Biogen Idec, Momenta, Sanofi-Genzyme and DARPA headline the event
BOSTON--(BUSINESS WIRE)--IBC Life Sciences, the organizer of market leading events in drug discovery, diagnostics, biologics development, production and delivery today unveiled the headline keynotes for BioProcess International (BPI) conference and exhibition, October 20-23 at the Hynes Convention Center in Boston, MA. This year’s keynote presentations feature several of the leading scientific leaders in the business of developing next-generation biologics. BPI is the largest annual event where all segments involved in the development and manufacture of biologics gathers to network, collaborate and learn about the most advanced bioprocessing methods. For the entire BPI program, visit: http://www.IBCLifeSciences.com/BPI.
“Bioprocess innovation plays a key role in responding to the economic and regulatory pressures on the BioPharma industry. Advances in our speed to market, product compliance, patient access and the patient experience all depend on continued innovation in our processes and capabilities.”
Commenting on the drive for continual biological innovation, Ralph Lambalot, Ph.D., Vice President, Biologics Development, AbbVie said, “Bioprocess innovation plays a key role in responding to the economic and regulatory pressures on the BioPharma industry. Advances in our speed to market, product compliance, patient access and the patient experience all depend on continued innovation in our processes and capabilities.”
BPI 2014 keynote presentations feature:
Understanding Complexity in Biological Systems through Big Data Analytics- Applications to Biosimilars and Novel Biologics presented by Ganesh V. Kaundinya, Ph.D., Co-Founder and Chief Scientific Officer, Momenta Pharmaceuticals.
Delivering Innovation in Biotherapeutic Manufacturing: From Continuous Improvement to Disruptive Innovation, What Can Current Industry Trends Tell Us About the Next 10 Years? presented by Ralph Lambalot, Ph.D., Vice President, Biologics Development, AbbVie.
Delivering on a Global Biopharmaceutical Portfolio: Biogen Idec's Strategy for Success through Innovations in R&D, Protein Development and Manufacturing presented by John G. Cox, Executive Vice President, Pharmaceutical Operations & Technology, Biogen Idec.
Keeping the Patient's and Caregiver's Experience in Mind presented by Robert Mattaliano, Ph.D., Group Vice President and Head of Biologics, Sanofi-Genzyme R&D Center.
Biologically-derived Medicines on Demand for Battlefield Medicine presented by Geoffrey Ling, M.D., Ph.D., Director, Biological Technologies Office, DARPA.
BPI is the leading event covering the full bioprocessing spectrum including, cell culture, recovery and purification, formulation and delivery, manufacturing strategy, analytical and quality and new sessions for early-stage companies on moving quickly from IND to the clinic.
A major new attraction launched at BPI 2014 is the BPI Theater, specially designed to showcase the latest products and innovations from the industry’s leading companies and scientific pioneers.
Enhancing the productivity of BPI delegates is access to partnering360®, the largest online network of life science dealmakers. BPI delegates gain exclusive access to a BPI specific partnering360® networking tool enabling them to identify and schedule meetings with potential partners, and foster deeper engagement before, during and following the event.
Significant partnering opportunities exist for biopharmaceutical firms developing new and improved biologics including mAbs, vaccines, ADCs, recombinant proteins, bispecifics, enzymes, biosimilars and cell therapies.
BioProcess International conference programming is held on October 20-23, 2-day training courses on October 21-22 and the exhibition is October 21-23. Complete details on this event can be found at www.IBCLifeSciences.com/BPI or to receive a press pass or arrange an interview with a speaker, email Dawn O’Connor at email@example.com.
About IBC Life Sciences
IBC Life Sciences, a division of Informa, is your connection to the life sciences industry. Through conferences, webinars, podcasts and its suite of integrated marketing solutions, IBC Life Sciences delivers expert knowledge, valuable connections and customized offerings so customers can meet their goals. www.IBCLifeSciences.com
IBC Life Sciences hosts the annual BioProcess International™ (BPI) Conference and Exhibition. The BioProcess International Conference & Exhibition is where the biologics value chain meets to do business. Each year BPI attracts over 1500 biologics industry leaders for four days of power networking and learning. No other industry event delivers the high-level connections and insight needed to accelerate your business. Use this preeminent industry platform to showcase your company, products and thought leadership. To get involved, visit www.IBCLifeSciences.com/BPI.